MDMA 2019 FDA Forum
7:30am - 12:00pm
Have you ever left a conference and realized that you forgot to ask the question you came to get answered? Ever wonder what the FDA’s criteria may be when reviewing your PMA/510(k) submission? Join us at MDMA’s FDA Forum on March 14-15, 2019 in Palo Alto, CA to get your questions answered.
MDMA’s 2019 FDA Forum continues to grow as THE conference to engage with leading policy makers and experts. Be sure not to miss out hearing from FDA officials on how to get your technologies into the marketplace.
Confirmed FDA Speakers Include:
*William Maisel, Deputy Center Director for Science & Chief Scientist, CDRH, FDA
*Sergio de del Castillo, De Novo Program Lead, ODE, CDRH, FDA
*Joshua Nipper, Director, PMA, HDE & Q-Sub Programs, Program Operations Staff, ODE, CDRH, FDA
*Kathryn O’Callaghan, Assistant Director for Strategic Programs, Office of the Center Director, CDRH, FDA
*Bakul Patel, Associate Director for Digital Health, Office of the Center Director, CDRH, FDA
*Marjorie Shulman, Chief of Premarket Notification (510(k)) Section, ODE, CDRH, FDA
*Timothy Stenzel, Director, Office of In Vitro Diagnostics & Radiological Health, CDRH, FDA
*Michelle Tarver, Director, Patient Science & Engagement Program, Office of the Center Director, CDRH, FDA
This is a RARE opportunity to share YOUR concerns and ask YOUR questions from some of the FDA’s top officials.
MDMA Members – $595
State Member – $795
Non-Members – $895
Contact: Sheri DeVinney
Contact Phone: 202-354-7171
Contact Email: email@example.com
Crowne Plaza Cabana Hotel
4290 El Camino Real
Palo Alto, CA 94306